113 related articles for article (PubMed ID: 7779984)
1. [Modulation of the level of sphingomyelin cycle products and expression of the CD3 receptor in immunocompetent organs by fumonisin B1].
Martynova EA; Solov'ev AS; Khrenov AV; Zabotina TN; Alesenko AV
Biokhimiia; 1995 Apr; 60(4):618-25. PubMed ID: 7779984
[TBL] [Abstract][Full Text] [Related]
2. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
3. A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction.
Tonnetti L; Verí MC; Bonvini E; D'Adamio L
J Exp Med; 1999 May; 189(10):1581-9. PubMed ID: 10330437
[TBL] [Abstract][Full Text] [Related]
4. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis.
Jaffrézou JP; Levade T; Bettaïeb A; Andrieu N; Bezombes C; Maestre N; Vermeersch S; Rousse A; Laurent G
EMBO J; 1996 May; 15(10):2417-24. PubMed ID: 8665849
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma.
Wakita H; Nishimura K; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Sep; 107(3):336-42. PubMed ID: 8751967
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelin-ceramide turnover in CD28 costimulatory signaling.
Chan G; Ochi A
Eur J Immunol; 1995 Jul; 25(7):1999-2004. PubMed ID: 7621875
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D metabolites activate the sphingomyelin pathway and induce death of glioblastoma cells.
Magrassi L; Adorni L; Montorfano G; Rapelli S; Butti G; Berra B; Milanesi G
Acta Neurochir (Wien); 1998; 140(7):707-13; discussion 713-4. PubMed ID: 9781285
[TBL] [Abstract][Full Text] [Related]
8. Targeted sphingolipid analysis in chickens suggests different mechanisms of fumonisin toxicity in kidney, lung, and brain.
Guerre P; Matard-Mann M; Nyvall Collén P
Food Chem Toxicol; 2022 Dec; 170():113467. PubMed ID: 36241089
[TBL] [Abstract][Full Text] [Related]
9. Content and structure of ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22.
Rylova SN; Somova OG; Zubova ES; Dudnik LB; Kogtev LS; Kozlov AM; Alesenko AV; Dyatlovitskaya EV
Biochemistry (Mosc); 1999 Apr; 64(4):437-41. PubMed ID: 10231598
[TBL] [Abstract][Full Text] [Related]
10. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise.
Dobrzyń A; Górski J
Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E277-85. PubMed ID: 11788358
[TBL] [Abstract][Full Text] [Related]
11. Ceramide triggers meiotic cell cycle progression in Xenopus oocytes. A potential mediator of progesterone-induced maturation.
Strum JC; Swenson KI; Turner JE; Bell RM
J Biol Chem; 1995 Jun; 270(22):13541-7. PubMed ID: 7768956
[TBL] [Abstract][Full Text] [Related]
12. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL.
Wiesner DA; Kilkus JP; Gottschalk AR; Quintáns J; Dawson G
J Biol Chem; 1997 Apr; 272(15):9868-76. PubMed ID: 9092523
[TBL] [Abstract][Full Text] [Related]
13. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
He X; Chen F; Gatt S; Schuchman EH
Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
[TBL] [Abstract][Full Text] [Related]
14. [Study of sphingomyelinase activity and sphingomyelin and ceramide levels in comparison with other lipid fractions of the cell nucleus in regenerating rat liver].
Pushkarev MIu; Borovkova OV; Alesenko AV
Biokhimiia; 1991 May; 56(5):903-12. PubMed ID: 1747416
[TBL] [Abstract][Full Text] [Related]
15. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis].
Serebrov VIu; Kuz'menko DI; Burov PG; Sapugol'tseva OB
Biomed Khim; 2010; 56(2):283-9. PubMed ID: 21341516
[TBL] [Abstract][Full Text] [Related]
16. Ligation of the WC1 receptor induces gamma delta T cell growth arrest through fumonisin B1-sensitive increases in cellular ceramide.
Kirkham PA; Takamatsu HH; Lam EW; Parkhouse RM
J Immunol; 2000 Oct; 165(7):3564-70. PubMed ID: 11034356
[TBL] [Abstract][Full Text] [Related]
17. Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells.
Cao LC; Honeyman T; Jonassen J; Scheid C
Kidney Int; 2000 Jun; 57(6):2403-11. PubMed ID: 10844609
[TBL] [Abstract][Full Text] [Related]
18. Implication of sphingomyelin/ceramide molar ratio on the biological activity of sphingomyelinase.
Boulgaropoulos B; Amenitsch H; Laggner P; Pabst G
Biophys J; 2010 Jul; 99(2):499-506. PubMed ID: 20643068
[TBL] [Abstract][Full Text] [Related]
19. [Correction of age-related changes in sphingolipid content in rat tissues by acid sphingomyelinase inhibition].
Har'kavenko VV; Storozhenko GB; Krasnikova OM; Babenko NO
Fiziol Zh (1994); 2012; 58(1):56-60. PubMed ID: 22590738
[TBL] [Abstract][Full Text] [Related]
20. Identification of N-acyl-fumonisin B1 as new cytotoxic metabolites of fumonisin mycotoxins.
Harrer H; Laviad EL; Humpf HU; Futerman AH
Mol Nutr Food Res; 2013 Mar; 57(3):516-22. PubMed ID: 23281112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
